BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 29794016)

  • 1. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity.
    Numata T; Yoshizaki T; Yamaguchi S; Shimura E; Iwakura Y; Harada K; Sudo K; Tsuboi R; Nakae S
    Biochem Biophys Res Commun; 2018 Nov; 506(3):429-436. PubMed ID: 30352688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
    Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability.
    Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH
    Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.
    Tortola L; Rosenwald E; Abel B; Blumberg H; Schäfer M; Coyle AJ; Renauld JC; Werner S; Kisielow J; Kopf M
    J Clin Invest; 2012 Nov; 122(11):3965-76. PubMed ID: 23064362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
    Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
    Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
    Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
    PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation.
    Uribe-Herranz M; Lian LH; Hooper KM; Milora KA; Jensen LE
    J Invest Dermatol; 2013 Jun; 133(6):1541-9. PubMed ID: 23407395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice.
    Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H
    Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
    Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.